Skip to main content
Log in

Irradiation parameters play a crucial role in the (n, γ) production of 170Tm suitable for clinical use in bone pain palliation

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

While neutron activation of natural Tm2O3 is the convenient strategy for producing 170Tm for use in palliative care of painful bone metastases, the coproduction of 171Tm (t ½ = 1.92 years) is as an impediment towards its clinical utility. The production strategy has been optimized to obtain 170Tm with adequate specific activity and radionuclidic purity. Preliminary clinical studies carried out using the 170Tm-labeled ethylenediaminetetramethylene phosphonic acid (170Tm-EDTMP) showed site specific localization of the radiopharmaceutical in skeleton with preferential accumulation in metastatic lesions along with almost no accumulation in non-target organs, a distribution pattern comparable to that of 99mTc-labeled methylene diphosphonate (99mTc-MDP).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Brasse D, Nonat A (2015) Radiometals: towards a new success story in nuclear imaging? Dalton Trans 44:4845–4848

    Article  CAS  Google Scholar 

  2. Carroll V, Demoin DW, Hoffman TJ, Jurisson SS (2012) Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions. Radiochim Acta 100:653–667

    Article  CAS  Google Scholar 

  3. Park JA, Kim JY (2013) Recent advances in radiopharmaceutical application of matched-pair radiometals. Curr Top Med Chem 13:458–469

    Article  CAS  Google Scholar 

  4. Cutler CS, Hennkens HM, Sisay N, Huclier-Markai S, Jurisson SS (2013) Radiometals for combined imaging and therapy. Chem Rev 113:858–883

    Article  CAS  Google Scholar 

  5. Das T, Chakraborty S, Sarma HD, Tandon P, Banerjee S, Venkatesh M, Pillai MR (2009) 170Tm-EDTMP: a potential cost-effective alternative to 89SrCl2 for bone pain palliation. Nucl Med Biol 36:561–568

    Article  CAS  Google Scholar 

  6. Vats K, Das T, Sarma HD, Banerjee S, Pillai MR (2013) Radiolabeling, stability studies, and pharmacokinetic evaluation of thulium-170-labeled acyclic and cyclic polyaminopolyphosphonic acids. Cancer Biother Radiopharm 28:737–745

    Article  CAS  Google Scholar 

  7. Polyak A, Das T, Chakraborty S, Kiraly R, Dabasi G, Joba RP, Jakab C, Thuroczy J, Postenyi Z, Haasz V, Janoki G, Janoki GA, Pillai MR, Balogh L (2014) Thulium-170-labeled microparticles for local radiotherapy: preliminary studies. Cancer Biother Radiopharm 29:330–338

    Article  CAS  Google Scholar 

  8. Quadramet (Samarium SM 153 Lexidronam Pentasodium)—Summary. http://www.druglib.com/druginfo/quadramet/

  9. Das T, Sarma HD, Shinto A, Kamaleshwaran K, Banerjee S (2014) Formulation, preclinical evaluation and preliminary clinical investigation of an in house freeze-dried EDTMP kit suitable for preparation of 177Lu-EDTMP. Cancer Biother Radiopharm. 29:412–420

    Article  CAS  Google Scholar 

  10. Cetnar J (2006) General solution of Bateman equations for nuclear transmutations. Ann Nucl Energy 33:640–645

    Article  CAS  Google Scholar 

  11. Ramamoorthy N, Saraswathy P, Das MK, Mehra KS, Ananthakrishnan M (2002) Production logistics and radionuclidic purity aspects of 153Sm for radionuclide therapy. Nucl Med Commun 23:83–89

    Article  CAS  Google Scholar 

  12. Chakraborty S, Das T, Banerjee S, Balogh L, Chaudhari PR, Sarma HD, Polyak A, Máthé D, Venkatesh M, Janoki G, Pillai MRA (2008) 177Lu-EDTMP: a viable bone pain palliative in skeletal metastasis. Cancer Biother Radiopharm 23:202–213

    Article  CAS  Google Scholar 

  13. Kawabe J, Higashiyama S, Shiomi S (2013) Clinical nuclear medicine in bone metastases. Clin Calcium 23:385–390

    Google Scholar 

  14. International Atomic Energy Agency. Operation Research Reactors in the World [database]. www.naweb.iaea.org/napc/physics/research_reactors/database/

Download references

Acknowledgments

Research at the Bhabha Atomic Research Centre is part of the ongoing activities of the Department of Atomic Energy, India and is fully supported by government funding. The authors are thankful to Dr. K. L. Ramakumar, Director, Radiochemistry and Isotope Group, Bhabha Atomic Research Centre for his valuable support to the Isotope Program. The authors gratefully acknowledge Dr. S.V. Thakare and Mr. K. C. Jagadeesan of Isotope Production and Applications Division, Bhabha Atomic Research Centre, for arranging the irradiation of Tm2O3 targets in reactor. The authors also sincerely acknowledge Dr. Tapas Das, Radiopharmaceutical Chemistry Section, Bhabha Atomic Research Centre for his efforts in formulating cold kits of EDTMP used for preparation of 170Tm-EDTMP at hospital radiopharmacy.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Sudipta Chakraborty or Ashutosh Dash.

Additional information

Mohammed Sahiralamkhan and Rubel Chakravarty have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sahiralamkhan, M., Chakravarty, R., Chakraborty, S. et al. Irradiation parameters play a crucial role in the (n, γ) production of 170Tm suitable for clinical use in bone pain palliation. J Radioanal Nucl Chem 307, 1105–1113 (2016). https://doi.org/10.1007/s10967-015-4323-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-015-4323-y

Keywords

Navigation